Name: Latest research reports of Ipca Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Motilal Oswal

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1409.7000 -30.10 (-2.09%)

NSE Dec 29, 2025 14:08 PM

Volume: 49,020

Ipca Laboratories Ltd.

14 Oct 2024

1409.70

-2.09%

At an inflexion point

Buy: Ipca Laboratories Ltd.

Recommendation Target

Motilal Oswal

After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.

Ipca Laboratories Ltd. has an average target of 1595.00 from 3 brokers.